IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ATXS

Balance Sheet

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents96.2876.3254.3959.8280.9087.21172.01175.53119.81133.96202.3020.5345.9729.8346.6986.51131.78139.52146.92
Short-term Investments131.44182.86240.68268.31263.38267.49197.9071.0069.0069.0011.03205.9170.6072.6566.1339.00----20.00
Accounts Receivable17.24------------------------------------
Total Current Assets253.55268.59302.97334.64351.86357.89374.52250.94191.47204.41215.45227.69118.49103.82114.22127.08134.52140.05147.68
Total Non-current Assets*18.3213.347.427.729.7810.104.293.722.402.642.802.941.331.470.430.440.610.891.06
Total Assets271.87281.92310.39342.36361.64367.99378.81254.67193.86207.05218.24230.63119.82105.29114.65127.51135.13140.95148.74
Accounts Payable1.140.743.704.321.282.340.861.511.140.830.930.790.791.000.931.560.570.621.81
Total Current Liabilities23.5218.0417.4319.1315.7216.3711.0711.559.386.606.679.066.445.234.975.204.703.994.41
Total Non-current Liabilities*15.103.373.673.974.264.540.000.000.000.050.210.360.500.650.000.000.000.064.60
Total Liabilities38.6121.4121.1023.1019.9920.9111.0711.559.386.656.889.426.955.874.975.204.704.059.00
Retained Earnings(773.20)(741.55)(708.50)(674.79)(649.17)(624.63)(600.46)(580.53)(549.12)(531.40)(518.83)(507.64)(494.38)(482.38)(471.13)(455.81)(446.32)(438.45)(430.98)
Total Stockholder Equity233.25260.51289.29319.26341.65347.08367.74243.12184.48200.40211.36221.22112.8799.42109.69122.31130.43136.90(101.14)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Total Revenue0.71------0.00----------------------------
Research & Development--------------------------------3.793.482.59
Selling, General & Admin10.669.889.219.438.508.098.427.336.906.015.464.704.694.835.023.814.114.012.88
Total Operating Expenses34.8135.8236.9929.5929.0128.8024.1534.2020.2415.1013.4914.2912.3911.4515.389.517.907.49170.09
Operating Income(34.10)(35.82)(36.99)(29.59)(29.01)(28.80)(24.15)(34.20)(20.24)(15.10)(13.49)(14.29)(12.39)(11.45)(15.38)(9.51)(7.90)(7.49)(170.08)
Net Income(31.64)(33.05)(33.71)(25.63)(24.53)(24.17)(19.93)(31.41)(17.73)(12.57)(11.19)(13.26)(12.00)(11.25)(15.32)(9.49)(7.87)(7.47)(170.08)
Basic EPS(0.55)(0.57)(0.58)(0.45)(0.42)(0.43)(0.38)(0.94)(0.63)(0.45)(0.40)(0.64)(0.87)(0.86)(1.18)3.23(0.61)----
Diluted EPS(0.55)(0.57)(0.58)(0.45)(0.42)(0.43)(0.38)(0.94)(0.63)(0.45)(0.40)(0.64)(0.87)(0.86)(1.18)3.23(0.61)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow(32.29)(36.06)(34.02)(17.36)(27.96)(16.79)(19.09)(30.24)(14.26)(10.70)(13.25)(10.66)(10.25)(10.06)(12.56)(6.29)(7.75)(7.40)(8.72)
Capital Expenditures0.000.59--0.000.020.31--0.020.000.000.010.030.060.00--0.000.000.000.02
Free Cash Flow*(32.29)(36.65)--(17.36)(27.98)(17.10)--(30.25)(14.26)(10.70)(13.26)(10.69)(10.31)(10.06)--(6.29)(7.75)(7.40)(8.74)
Investing Cash Flow52.2557.9928.58(3.72)6.19(68.10)(126.23)(2.02)-0.00(57.92)194.99(135.18)1.95(6.80)(27.10)(39.00)0.000.0026.45
Financing Cash Flow0.00----0.0015.300.09141.8187.980.110.270.04120.4024.32----0.020.010.00104.26
← Scroll for more columns →

* Derived from reported values